BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 19, 2012
View Archived Issues
Novel inhibitors of GlyT1 designed in Japan
Read More
Roche reviews developments of first quarter 2012
Read More
Eisai divulges new suppressors of prostanoid signaling
Read More
Collaboration yields novel potential therapies for hepatitis C
Read More
Investigators in U.S. link desaturase to survival of patients with breast cancer
Read More
Potential new antidepressant has promising pharmacokinetic profile
Read More
Novel microRNA-based drug shows potential to treat liver cancer
Read More
Potent ROCK inhibitors with oncolytic potential identified in U.S.
Read More
Novel antimalarials identified through phenotypic whole-cell screening
Read More
New P2X7 receptor antagonists patented by Merck & Co.
Read More
Takeda and Metabolon to collaborate on targets/biomarkers
Read More
Rockland Immunochemicals and LIMR enter commercialization agreement
Read More
Five Prime Therapeutics and GSK collaborate on respiratory diseases
Read More
Michael J. Fox Foundation funds to-BBB Parkinson's disease research
Read More
Sucampo and Clinigen implement named-patient program for Amitiza
Read More
ME-3738 program discontinued
Read More
Celek Pharmaceuticals provides update on progress for CEL-031
Read More
Eisai presents PARP inhibitor with promising anticancer activity
Read More
Argyle Therapeutics out-licenses topical rosacea treatment candidate
Read More
Tengion plans IND submission for Neo-Kidney Augment
Read More
Pluristem receives clearance for phase II PLX-PAD trial
Read More
FDA issues complete response letter for Pliaglis sNDA
Read More
MSD launches antifungal drug in Japan
Read More
BMS and Janssen expand collaboration on TMC-435 and BMS-790052
Read More
Bayer Yakuhin launches anticoagulant tablet in Japan
Read More
